Shukra Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.88",
    "chg": -0.3,
    "chgp": "-0.96%",
    "dir": -1,
    "prev_price": "31.18",
    "mcapval": "1,352.17 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE551C01044",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "3.03 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shukra Pharmaceuticals Gains 9.97%: Mixed Signals Shape Weekly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-gains-997-mixed-signals-shape-weekly-performance-3983611",
        "imagepath": "",
        "date": "2026-05-09 17:06:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 4:</strong> Bearish technical shift noted amid mixed momentum signals</p>\n                    <p><strong>May 5-7:</strong> Consecutive strong price gains with rising volumes</p>\n                    <p><strong>May 8:</strong> Mixed quarterly results reported, stock closes lower</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.30.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.33.54</div><div class=\"stat-change positive\">+9.97%</div></div>\n                    <div class=\"stat-i..."
      },
      {
        "title": "Are Shukra Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-shukra-pharmaceuticals-ltd-latest-results-good-or-bad-3982331",
        "imagepath": "",
        "date": "2026-05-08 19:18:18",
        "description": "Shukra Pharmaceuticals Ltd's latest financial results for the quarter ending March 2026 reveal significant operational challenges. The company's net sales experienced a dramatic decline of approximately 83.85% quarter-on-quarter, dropping to ₹6.32 crores from ₹39.13 crores in the previous quarter. This steep fall raises concerns about revenue recognition practices and suggests potential volatility in the company's operational performance.\n\nIn terms of profitability, Shukra Pharmaceuticals reported a net loss of ₹1.72 crores for the quarter, which reflects a substantial decline compared to the previous quarter's profit. The operating margin also contracted sharply to 11.08%, down from an exceptionally high 69.33% in the prior quarter. This compression in margins indicates a significant shift in the company's cost structure or product mix, which may have been influenced by pricing pressures or changes in dema..."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Reports Mixed Quarterly Results Amid Financial Trend Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-reports-mixed-quarterly-results-amid-financial-trend-shift-3981646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShukraPharmaceu_fintrenddot_3981646.png",
        "date": "2026-05-08 11:00:10",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its financial trend, moving from an outstanding to a positive performance rating in the latest quarter ending March 2026. Despite strong half-yearly sales and profit after tax (PAT) figures, the company’s most recent quarterly results reveal significant declines in revenue and profitability compared to its previous four-quarter averages, prompting a downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "When is the next results date for Shukra Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-shukra-pharmaceuticals-ltd-3970814",
        "imagepath": "",
        "date": "2026-04-30 23:16:00",
        "description": "The next results date for Shukra Pharmaceuticals Ltd is scheduled for 07 May 2026...."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-forms-death-cross-signalling-potential-bearish-trend-3970679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_dealthcross_3970679.png",
        "date": "2026-04-30 18:00:19",
        "description": "Shukra Pharmaceuticals Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s short- to medium-term momentum and raising concerns about its near-term price trajectory."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3969428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_technicaldot_3969428.png",
        "date": "2026-04-30 08:01:28",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s technical indicators present a complex picture, with bearish signals dominating weekly charts while monthly indicators offer a more nuanced outlook. This article analyses the latest price momentum, key technical indicators, and the implications for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd: Technical Momentum Shifts Signal Mild Bullish Outlook Amid Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-amid-volatility-3958367",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_technicaldot_3958367.png",
        "date": "2026-04-23 08:01:34",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance despite a recent 4.58% decline in its share price. The company’s technical indicators present a complex picture, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term prospects."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3955008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_technicaldot_3955008.png",
        "date": "2026-04-21 08:03:01",
        "description": "Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Sell to Hold as of 17 July 2025. Despite a recent day decline of 3.74%, the stock’s technical indicators present a complex picture with contrasting signals across weekly and monthly timeframes, suggesting a sideways trend after a period of mild bullishness."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Signal Mild Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-3950034",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_technicaldot_3950034.png",
        "date": "2026-04-17 08:01:41",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and technical parameter changes suggest cautious optimism for investors in this micro-cap pharmaceutical player."
      }
    ],
    "total": 15,
    "sid": "505931",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Appointment And Resignation Of Company Secretary & Compliance Officer",
      "datetime": "15-Jun-2026",
      "details": "Appointment and Resignation of Company Secretary & Compliance Officer",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Jun-2026",
      "details": "Newspaper Publication pertaining to EGM to be held on 6th July 2026",
      "source": "BSE"
    },
    {
      "caption": "Notice Of EGM To Be Held On 6Th July 2026",
      "datetime": "12-Jun-2026",
      "details": "Notice of EGM to be held on 6th July 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Shukra Pharmaceuticals Gains 9.97%: Mixed Signals Shape Weekly Performance

2026-05-09 17:06:37

Key Events This Week May 4: Bearish technical shift noted amid mixed momentum signals May 5-7: Consecutive strong price gains with rising volumes May 8: Mixed quarterly results reported, stock closes lower Week OpenRs.30.50 Week CloseRs.33.54+9.97% <div class="stat-i...

Are Shukra Pharmaceuticals Ltd latest results good or bad?

2026-05-08 19:18:18

Shukra Pharmaceuticals Ltd's latest financial results for the quarter ending March 2026 reveal significant operational challenges. The company's net sales experienced a dramatic decline of approximately 83.85% quarter-on-quarter, dropping to ₹6.32 crores from ₹39.13 crores in the previous quarter. This steep fall raises concerns about revenue recognition practices and suggests potential volatility in the company's operational performance. In terms of profitability, Shukra Pharmaceuticals reported a net loss of ₹1.72 crores for the quarter, which reflects a substantial decline compared to the previous quarter's profit. The operating margin also contracted sharply to 11.08%, down from an exceptionally high 69.33% in the prior quarter. This compression in margins indicates a significant shift in the company's cost structure or product mix, which may have been influenced by pricing pressures or changes in dema...

Shukra Pharmaceuticals Ltd Reports Mixed Quarterly Results Amid Financial Trend Shift

2026-05-08 11:00:10

Shukra Pharmaceuticals Ltd has experienced a notable shift in its financial trend, moving from an outstanding to a positive performance rating in the latest quarter ending March 2026. Despite strong half-yearly sales and profit after tax (PAT) figures, the company’s most recent quarterly results reveal significant declines in revenue and profitability compared to its previous four-quarter averages, prompting a downgrade in its Mojo Grade from Hold to Sell.

When is the next results date for Shukra Pharmaceuticals Ltd?

2026-04-30 23:16:00

The next results date for Shukra Pharmaceuticals Ltd is scheduled for 07 May 2026....

Shukra Pharmaceuticals Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-04-30 18:00:19

Shukra Pharmaceuticals Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s short- to medium-term momentum and raising concerns about its near-term price trajectory.

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-30 08:01:28

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s technical indicators present a complex picture, with bearish signals dominating weekly charts while monthly indicators offer a more nuanced outlook. This article analyses the latest price momentum, key technical indicators, and the implications for investors navigating the Pharmaceuticals & Biotechnology sector.

Shukra Pharmaceuticals Ltd: Technical Momentum Shifts Signal Mild Bullish Outlook Amid Volatility

2026-04-23 08:01:34

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance despite a recent 4.58% decline in its share price. The company’s technical indicators present a complex picture, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term prospects.

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-21 08:03:01

Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Sell to Hold as of 17 July 2025. Despite a recent day decline of 3.74%, the stock’s technical indicators present a complex picture with contrasting signals across weekly and monthly timeframes, suggesting a sideways trend after a period of mild bullishness.

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Signal Mild Bullish Outlook

2026-04-17 08:01:41

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and technical parameter changes suggest cautious optimism for investors in this micro-cap pharmaceutical player.

View All News